Novavax CEO: Our COVID-19 Vaccine Appeals To The Vaccine-hesitant | On Leading

Novavax CEO on Covid Vaccine Approval, Omicron EfficacyПодробнее

Novavax CEO on delayed U.S. Covid-19 vaccine trialПодробнее

Novavax CEO expects COVID vaccine to be approved within monthsПодробнее

Novavax could be alternative for COVID-19 vaccine hesitant, if approvedПодробнее

Novavax CEO: ‘We’re on track’ to deliver a couple billion COVID-19 vaccine doses this yearПодробнее

Novavax CEO: FDA filing for Covid-19 vaccine may happen next weekПодробнее

Novavax CEO: We can now make Covid vaccine at competitive commercial levelsПодробнее

Novavax CEO says COVID-19 vaccine will roll out 'very quickly'Подробнее

Novavax CEO Stanley Erck on the company's Covid-19 vaccineПодробнее

COVID VACCINE HESITANT? This is YOUR VACCINE!Подробнее

Coronavirus vaccine: Novavax CEO discusses variants and vaccine efficacyПодробнее

Novavax COVID-19 vaccine will be available ‘next week,’ CEO saysПодробнее

Novavax CEO on $1.6 billion in federal funding, Covid-19 vaccine progress and moreПодробнее

Novavax Vaccine Will Probably Work on New Covid Strain: CEOПодробнее

Novavax CEO discusses Covid vaccine, which was cleared for use in the EUПодробнее

Novavax CEO on COVID-19 boosters: ‘I dont think we’re too late’Подробнее

Novavax Vaccine in 'Good Shape' for Approval Filing: CEOПодробнее

Novavax to File Vaccine in U.K. and U.S. in Q2, CEO SaysПодробнее

Novavax CEO says company at 'tipping point' with COVID-19 vaccineПодробнее